Cargando…

Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions

BACKGROUND: Parkinson’s disease (PD) is a systemic disease clinically defined by the degeneration of dopaminergic neurons in the brain. While alterations in the gut microbiome composition have been reported in PD, their functional consequences remain unclear. Herein, we addressed this question by an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldini, Federico, Hertel, Johannes, Sandt, Estelle, Thinnes, Cyrille C., Neuberger-Castillo, Lorieza, Pavelka, Lukas, Betsou, Fay, Krüger, Rejko, Thiele, Ines
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285525/ https://www.ncbi.nlm.nih.gov/pubmed/32517799 http://dx.doi.org/10.1186/s12915-020-00775-7

Ejemplares similares

Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson’s Disease
por: Hertel, Johannes, et al.
Publicado: (2019)

Multilingual Validation of the First French Version of Munich Dysphagia Test—Parkinson's Disease (MDT-PD) in the Luxembourg Parkinson's Study
por: Simons, Janine A., et al.
Publicado: (2019)

Fitness for purpose of stabilized stool samples for bile acid metabolite analyses
por: Neuberger-Castillo, Lorie, et al.
Publicado: (2021)

The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis
por: Hipp, Geraldine, et al.
Publicado: (2018)

Prevalence and Cost of Care for Parkinson’s Disease in Luxembourg: An Analysis of National Healthcare Insurance Data
por: Schmitz, Susanne, et al.
Publicado: (2022)

LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary
por: Krüger, Rejko
Publicado: (2008)

Body-First Subtype of Parkinson’s Disease with Probable REM-Sleep Behavior Disorder Is Associated with Non-Motor Dominant Phenotype
por: Pavelka, Lukas, et al.
Publicado: (2022)

Early-to-mid stage idiopathic Parkinson’s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females
por: Capelle, Christophe M., et al.
Publicado: (2023)

Missing heritability in Parkinson’s disease: the emerging role of non-coding genetic variation
por: Ohnmacht, Jochen, et al.
Publicado: (2020)

Exploring the contribution of the mitochondrial disulfide relay system to Parkinson’s disease: the PINK1/CHCHD4 interplay
por: Arena, Giuseppe, et al.
Publicado: (2021)

Causal inference on microbiome-metabolome relations in observational host-microbiome data via in silico in vivo association pattern analyses
por: Hertel, Johannes, et al.
Publicado: (2023)

Excess of singleton loss-of-function variants in Parkinson’s disease contributes to genetic risk
por: Bobbili, Dheeraj Reddy, et al.
Publicado: (2020)

Effects of Subthalamic Nucleus Stimulation on Emotional Prosody Comprehension in Parkinson's Disease
por: Brück, Carolin, et al.
Publicado: (2011)

Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme
por: Mencke, Pauline, et al.
Publicado: (2020)

Management of Parkinson’s Disease 20 Years from Now: Towards Digital Health Pathways
por: Klucken, Jochen, et al.
Publicado: (2018)

The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's Disease
por: Grossmann, Dajana, et al.
Publicado: (2020)

Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study
por: Pachchek, Sinthuja, et al.
Publicado: (2023)

The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson’s Disease
por: Mencke, Pauline, et al.
Publicado: (2021)

Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
por: Farrer, Matthew J., et al.
Publicado: (2021)

Effects of Subthalamic and Nigral Stimulation on Gait Kinematics in Parkinson’s Disease
por: Scholten, Marlieke, et al.
Publicado: (2017)

Determinants of Self-Stigma in People with Parkinson’s Disease: A Mixed Methods Scoping Review
por: Hanff, Anne-Marie, et al.
Publicado: (2022)

Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
por: Krüger, Rejko, et al.
Publicado: (2017)

Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study
por: Chase, Bruce A., et al.
Publicado: (2023)

Retrograde Procedural Memory in Parkinson’s Disease: A Cross-Sectional, Case-Control Study
por: Pauly, Laure, et al.
Publicado: (2022)

Metabolic modelling reveals broad changes in gut microbial metabolism in inflammatory bowel disease patients with dysbiosis
por: Heinken, Almut, et al.
Publicado: (2021)

Anodal tDCS modulates cortical activity and synchronization in Parkinson's disease depending on motor processing
por: Schoellmann, Anna, et al.
Publicado: (2019)

Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
por: Pavelka, L., et al.
Publicado: (2022)

Glucocerebrosidase and its relevance to Parkinson disease
por: Do, Jenny, et al.
Publicado: (2019)

Personalized whole‐body models integrate metabolism, physiology, and the gut microbiome
por: Thiele, Ines, et al.
Publicado: (2020)

Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study
por: Fründt, Odette, et al.
Publicado: (2023)

Microbiome, Parkinson’s Disease and Molecular Mimicry
por: Miraglia, Fabiana, et al.
Publicado: (2019)

Microbiome changes: an indicator of Parkinson’s disease?
por: Haikal, Caroline, et al.
Publicado: (2019)

Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire
por: Becker, Sara, et al.
Publicado: (2021)

Combined STN/SNr-DBS for the treatment of refractory gait disturbances in Parkinson's disease: study protocol for a randomized controlled trial
por: Weiss, Daniel, et al.
Publicado: (2011)

Publisher Correction: Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
por: Pavelka, L., et al.
Publicado: (2022)

The Microbiome Modeling Toolbox: from microbial interactions to personalized microbial communities
por: Baldini, Federico, et al.
Publicado: (2019)

Model-based dietary optimization for late-stage, levodopa-treated, Parkinson’s disease patients
por: Guebila, Marouen Ben, et al.
Publicado: (2016)

Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial
por: Weiss, Daniel, et al.
Publicado: (2013)

Autoimmunity, dendritic cells and relevance for Parkinson’s disease
por: Koutsilieri, E., et al.
Publicado: (2012)

Drug repurposing strategies of relevance for Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dl4sovmnl9o9bblihb6cd31ths